1398 related articles for article (PubMed ID: 27557810)
1. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
[TBL] [Abstract][Full Text] [Related]
2. A case of IgG4-related lung disease complicated by asymptomatic chronic Epstein-Barr virus infection.
Kotetsu Y; Ikegame S; Takebe-Akazawa K; Koga T; Okabayashi K; Takata S
Clin Respir J; 2017 Nov; 11(6):1012-1017. PubMed ID: 26808729
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in elderly patients. Report of three cases.
Kojima M; Yamane Y; Itoh H; Tanaka H; Sugihara S; Masawa N; Nakamura S
APMIS; 2003 Dec; 111(12):1083-8. PubMed ID: 14678016
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
5. A case of Epstein-Barr virus-related lymphadenopathy mimicking the clinical features of IgG4-related disease.
Wada Y; Kojima M; Yoshita K; Yamazaki M; Kobayashi D; Murakami S; Nishi S; Nakano M; Narita I
Mod Rheumatol; 2013 May; 23(3):597-603. PubMed ID: 22842848
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary manifestation of immunoglobulin G4-related disease in a 7-year-old immunodeficient boy with Epstein-Barr virus infection: a case report.
Szczawinska-Poplonyk A; Wojsyk-Banaszak I; Jonczyk-Potoczna K; Breborowicz A
Ital J Pediatr; 2016 Jun; 42(1):58. PubMed ID: 27277432
[TBL] [Abstract][Full Text] [Related]
7. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
10. Hypocomplementemic urticarial vasculitis arising in a patient with immunoglobulin G4-related disease.
Takao M; Hamada T; Kaji T; Ikeda-Mizuno K; Takehara-Yasuhara C; Ichimura K; Yanai H; Yshino T; Iwatsuki K
Int J Dermatol; 2016 Apr; 55(4):430-3. PubMed ID: 26276260
[TBL] [Abstract][Full Text] [Related]
11. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
Yamamoto N; Nishimura N; Takeuchi M; Ito T; Yokozaki H; Hirase S; Kubokawa I; Mori T; Yanai T; Hayakawa A; Takeshima Y; Nishio H; Matsuo M; Imadome K; Iijima K
Eur J Pediatr; 2014 Dec; 173(12):1615-8. PubMed ID: 24169729
[TBL] [Abstract][Full Text] [Related]
12. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
[TBL] [Abstract][Full Text] [Related]
13. Systematic Epstein-Barr virus-positive T-cell lymphoproliferative disease presenting as a persistent fever and cough: a case report.
Ameli F; Ghafourian F; Masir N
J Med Case Rep; 2014 Aug; 8():288. PubMed ID: 25163591
[TBL] [Abstract][Full Text] [Related]
14. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.
Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T
Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders presented as interstitial pneumonia; successful recovery with rituximab.
Kunitomi A; Arima N; Ishikawa T
Haematologica; 2007 Apr; 92(4):e49-52. PubMed ID: 17562592
[TBL] [Abstract][Full Text] [Related]
17. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder].
Tanioka R; Mori S; Nakanishi T; Fujita S; Nakamichi N; Tajima K; Uemura Y; Amakawa R; Kishimoto Y; Fukuhara S
Rinsho Ketsueki; 2007 Nov; 48(11):1492-7. PubMed ID: 18080508
[TBL] [Abstract][Full Text] [Related]
18. Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports.
Zoshima T; Yamada K; Hara S; Mizushima I; Yamagishi M; Harada K; Sato Y; Kawano M
Am J Surg Pathol; 2016 Apr; 40(4):495-501. PubMed ID: 26598921
[TBL] [Abstract][Full Text] [Related]
19. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorder of the airway of an adolescent without immunodeficiency.
Boesch RP; Daines M; Kaul A; Cotton R; Amin R
Int J Pediatr Otorhinolaryngol; 2005 Nov; 69(11):1591-4. PubMed ID: 15963576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
